Antigua and Barbuda vs Saint Kitts and Nevis: Hepatitis B surface antigen (HBsAg) prevalence
Antigua and Barbuda
0.2%
in 2024
Saint Kitts and Nevis
0.2%
in 2024
Antigua and Barbuda rank
82nd
Saint Kitts and Nevis rank
82nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Antigua and Barbuda
- Saint Kitts and Nevis
How they compare
Antigua and Barbuda currently reports 0.2% against 0.2% in Saint Kitts and Nevis, a difference of 0.0%.
Across all 10 years both countries report, Saint Kitts and Nevis has been ahead every year.
Antigua and Barbuda ranks 82nd and Saint Kitts and Nevis ranks 82nd of 194 countries.
Head to head by decade
| Decade | Antigua and Barbuda | Saint Kitts and Nevis | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.0% | — |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Antigua and Barbuda or Saint Kitts and Nevis?
- Antigua and Barbuda, at 0.2% against 0.2% in Saint Kitts and Nevis as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Antigua and Barbuda and Saint Kitts and Nevis?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Saint Kitts and Nevis?
- 10 years are reported by both, from 2015 to 2024.
- How do Antigua and Barbuda and Saint Kitts and Nevis rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Antigua and Barbuda ranks 82nd and Saint Kitts and Nevis ranks 82nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.